Terapi Laser untuk Lesi Hiperpigmentasi
DOI:
https://doi.org/10.55175/cdk.v50i8.757Kata Kunci:
Hiperpigmentasi, intense pulsed light, laserAbstrak
Seiring dengan berkembangnya teknologi, laser dan intense pulsed light (IPL) menjadi pilihan modalitas terapi hiperpigmentasi. Kedalaman penetrasi sinar laser meningkat seiring meningkatnya panjang gelombang. Laser dan IPL dengan panjang gelombang pendek efektif untuk lesi hiperpigmentasi superfisial. Sedangkan lesi hiperpigmentasi dermal dan campuran lebih merespons terhadap laser dengan panjang gelombang yang lebih panjang. Pemilihan parameter laser serta persiapan sebelum dan setelah tindakan yang tepat dapat mengurangi risiko efek samping.
With the rapid evolution of technology, laser and intense pulsed light (IPL) have become one of the modalities of choice for hyperpigmentation therapy. The depth of laser beam penetration increases with increasing wavelength. Laser and IPL with short wavelength are effective to treat superficial hyperpigmentations. While dermal and mixed type hyperpigmentations have better response towards lasers with longer wavelength. Accurate laser parameter choice and good pre and post procedural preparations reduce the risk of side effects.
Unduhan
Referensi
Kilmer SL, Garden JM. Laser treatment of pigmented lesions and tattoos. Seminars in Cutaneous Med Surg. 2000;19(4):232-44.
Bonan P, Bruscino N. Laser and light-based treatments for pigmented lesions. The PMFA J. 2018;5(2).
Alster TS, Lupton JR. Laser therapy for cutaneous hyperpigmentation and pigmented lesions. Dermatol Ther. 2001;14:46-54.
Dierickx CC. Laser treatment of pigmented lesions. In: Goldberg DJ, eds. Laser dermatology. Berlin, Heidelberg: Springer; 2005.
Carroll L, Humphreys TR. Laser-tissue interactions. Clin Dermatol 2006;24:2-7
Nieuweboer-Krobotova L. Hyperpigmentation: Type, diagnostics, and targeted treatment options. JEADV. 2013;27(1):2-4.
Nautiyal A, Wairkar S. Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell Melanoma 2021;34:1000-14.
Passeron T, Genedy R, Salah L, Fusade T, Kositratna G, Laubach HJ, et al. Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology. J Eur Acad Dermatol Venereol. 2019;33(6):987-1005. doi: 10.1111/jdv.15497.
Ibrahim O, Dover JS. Fundamentals of laser and light-based treatments. In: Kang S, Amagai M, Bruckner AL, eds. Fitzpatricks’s dermatology. 9th Ed. New York: McGraw-Hill Education; 2019 .p. 3827.
Polder KD, Landau JM, Vergilis-Kalner IJ, Goldberg LH, Friedman PM, Bruce S. Laser eradication of pigmented lesions: A review. Dermatol Surg. 2011;37:572-95.
Horner MB. El-Muttardi NS. Mayou BJ. Treatment of congenital melanocytic naevi with CO2 laser. Ann Plastic Surg. 2005;55(3):276-80.
Grekin RC, Shelton RM, Geisse JK, Frieden I. 510-nm pigmented lesion dye laser. J Dermatol Surg Oncol. 1993;19(4):380-7.
Alster TS. Complete elimination of large café-au-lait birthmarks by the 510-nm pulsed dye laser. Plast Reconstr Surg. 1995;96(7):1660-4. doi: 10.1097/00006534-199512000-00020.
Suh DH, Han KH, Chung JH. The use of Q-switched Nd: YAG laser in the treatment of superficial pigmented lesions in Koreans. J Dermatol Treat 2001;12:91-6.
Grevelink JM, Gonzalez S, Bonoan R, Vibhagool C, Gonzalez E. Treatment of nevus spilus with the Q-switched ruby laser. Dermatol Surg. 1997;23:365-9.
Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium:yttrium aluminium garnet laser. A comparative study. J Dermatol Surg Oncol. 1994;20:795-800.
Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur Acad Dermatol Venereol. 2009;34:847-50.
Cho SB, Park S, Kim J, Kim M. Treatment of post-inflammatory hyperpigmentation using 1064-nm Q-switched Nd: YAG laser with low fluence: Report of three cases. J Eur Acad Dermatol Venereol. 2009;23(10):1206-07.
Mokos ZB, Lipozencic J, Ceovic R, Buzina DS, Kostovic K. Laser therapy of pigmented lesions: Pro and contra. Acta Dermatovenerol Croat 2010;18(3):185-9.
Sadighha A, Saatee S, Muhaghegh-Zahed G. Efficacy and adverse effects of Q-switched ruby laser on solar lentigines: A prospective study of 91 patients with Fitzpatrick skin type II, III, and IV. Dermatol Surg. 2008;34:1465-8.
Taylor Cr, Anderson RR. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Int J Dermatol. 1993;32(12):908-12.
Ueda S, Isoda M, Imayama S. Response of naevus of Ota to Q-switched ruby laser treatment according to lesion colour. Br J Dermatol. 2000;142:77-83.
Kono T, Ercocen AR. Treatment in congenital melanocytic nevi using the combined (normal-mode plus Q-switched) ruby lasers in Asians. Ann Plastic Surg. 2005;54(5):494-501.
Kagami S, Asahina A, Watanabe R, Mimura Y, Shirai A, Hattori N, et al. Treatment of 153 Japanese patients with Q-switched alexandrite laser. Lasers Med Sci. 2007;22(3):159-63. doi: 10.1007/s10103-006-0436-4.
Chan HH, Leung RS, Ying SY, Lai CF, Kono T, Chua JK, et al. A retrospective analysis of complications in the treatment of nevus of Ota with the Q-switched alexandrite and Q-switched Nd: YAG lasers. Dermatol Surg. 2000;26:1000-6.
Wang CC, Sue YM, Yang CH, Chen CK. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: A randomized, physician-blinded, split-face comparative trial. J Am Acad Dermatol. 2006;54:804-10.
Alshami MA. Long-pulsed 532-nm Nd: YAG laser treatment for small acquired melanocytic nevi in a single session: An 8-year study on 350 Yemeni patients. J Cosmet Laser Ther. 2014;16(1):14-20.
Bjerring P, Christiansen K. Intense pulsed light source for treatment of small melanocytic nevi and solar lentigines. J Cutaneous Laser Ther. 2001;2(4):177-81.
Navratil L. Kymplova J. Contraindications in noninvasive laser therapy: Truth and fiction. J Clin Laser Med Surg. 2002;20(6):341-43.
Alkhafilah A. A case report of vitiligo induced by alexandrite hair removal laser. Case Rep Dermatol. 2021;13:521-4.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2023 Cermin Dunia Kedokteran
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
